Medical cannabis can take up between $311 – $388 million of pharma sales by 2024.
Apinya will produce full-spectrum extracts as well as isolated cannabinoid extracts for the domestic and international markets. Cannabis derived extracts with varying compositions and concentrations of THC, CBD and other cannabinoids will be developed and cultivated. Center of cultivation and production will be our facility at the campus of the University of Phayao.